326 related articles for article (PubMed ID: 27082640)
1. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
2. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.
Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC
J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
[TBL] [Abstract][Full Text] [Related]
4. Essential role of RSK2 in c-Fos-dependent osteosarcoma development.
David JP; Mehic D; Bakiri L; Schilling AF; Mandic V; Priemel M; Idarraga MH; Reschke MO; Hoffmann O; Amling M; Wagner EF
J Clin Invest; 2005 Mar; 115(3):664-72. PubMed ID: 15719069
[TBL] [Abstract][Full Text] [Related]
5. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
[TBL] [Abstract][Full Text] [Related]
6. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
Linder M; Glitzner E; Srivatsa S; Bakiri L; Matsuoka K; Shahrouzi P; Dumanic M; Novoszel P; Mohr T; Langer O; Wanek T; Mitterhauser M; Wagner EF; Sibilia M
EMBO Mol Med; 2018 Nov; 10(11):. PubMed ID: 30361264
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
[TBL] [Abstract][Full Text] [Related]
8. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
9. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
[TBL] [Abstract][Full Text] [Related]
10. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
12. Effect of CXCR4 on Apoptosis in Osteosarcoma Cells via the PI3K/Akt/NF-κβ Signaling Pathway.
Jiang C; Ma S; Hu R; Wang X; Li M; Tian F; Jiang W; Zhu L; Bian Z
Cell Physiol Biochem; 2018; 46(6):2250-2260. PubMed ID: 29734183
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
14. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
16. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
[TBL] [Abstract][Full Text] [Related]
17. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
18. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
[TBL] [Abstract][Full Text] [Related]
19. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway.
Hao L; Liao Q; Tang Q; Deng H; Chen L
Biochem Biophys Res Commun; 2016 Feb; 470(3):643-649. PubMed ID: 26797271
[TBL] [Abstract][Full Text] [Related]
20. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]